Geode Capital Management increased its stake in Ligand Pharmaceuticals and filed required reports with the SEC.

The entities involved

• Geode Capital Management →

  American Investment Management firm based in Boston, Massachusetts

  • Geode Capital Management acquired a new stake in Walmart shares during Q4.Mon 02:10
  • Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05
• Ligand Pharmaceuticals →

  biopharmaceutical company based out of La Jolla, California

  • Ligand Pharmaceuticals committed funding and royalty rights to AvenCell Therapeutics, Inc.Sun 17:54
• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12

Related events

• Geode Capital Management increased its holdings in Omnicom Group, while Citigroup lowered its price target and rating.Sep 6
• Geode Capital Management lifted its position in Ionis Pharmaceuticals stock, which is listed on Nasdaq and filed with the SEC.Sep 3
• Geode Capital Management increased its stake in Sensient Technologies stock on September 10, 2026.Sep 10
• Geode Capital Management and Norges Bank increased their positions in Terreno Realty Corporation on September 26, 2026.Sat 07:54
• Geode Capital Management increased its holdings in Aquestive Therapeutics, Inc. on September 12, 2026.Sep 12